Home›Search›Diabetes Therapy

Diabetes Therapy

Springer Publishing Company · United States · Est. 2010

ISSN1869-6961

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

days submission → published

measured · last 20 articles · accept 59d

weeks to publish · journal-reported

Fast · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.137

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.949

Total Worksi

1,859

Total Citationsi

36,152

2yr Mean Citednessi

4.52

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Diabetes Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of diabetes and related disorders, including obesity and metabolic syndromes.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2010

Annual Volume~ 156 articles / year

StatusActive (last: 2026)

Total Publications1,859

Publisher OrgAdis, Springer Healthcare

OA Since2009

Visit Journal Website

Submission Info

APC Cost$7,675Above median

Peer ReviewSingle-blind

Review Time~6 weeks

Acceptance Rate—

OA LicenseCC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

11/12 · 92%

✅

Do you know the journal / publisher?

Springer Publishing Company

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1869-6961

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

$7,675

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

194

4.4k

2019

235

5.8k

2020

207

3.7k

2021

153

1.5k

2022

159

1.6k

2023

163

1.4k

2024

147

416

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Internal MedicineQ1

Endocrinology, Diabetes and MetabolismQ2

Subject Classification

Web of Science Categories

Endocrinology & Metabolism

Scopus Categories

Endocrinology, Diabetes and MetabolismInternal Medicine

Research Topics (OpenAlex)

Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and EducationPancreatic function and diabetesMetabolism, Diabetes, and CancerDiabetes and associated disordersBariatric Surgery and OutcomesMedication Adherence and Compliance

Frequently asked questions about Diabetes Therapy

Is Diabetes Therapy a predatory journal?

PubScope has no integrity flags on record for Diabetes Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Diabetes Therapy?

Diabetes Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.52.

Is Diabetes Therapy indexed in Scopus and Web of Science?

Diabetes Therapy is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Diabetes Therapy?

How much does it cost to publish in Diabetes Therapy?

Diabetes Therapy charges an article processing charge (APC) of about $7,675 for open-access publication.